Free equity investment tool of Japanese companies

Credit Rating Analysis

Annual

First quarter

Second quarter

Third quarter

Sponsored Link

Related Company

TOKYO BOEKI

マルイチ産商

小津産業

KYODO PAPER HOLDINGS

COSMO BIO COMPANY,LIMITED

CHARLE

Carchs Holdings

Chiyoda Kohan

DAIKO DENSHI TSUSHIN

TSUKAMOTO CORPORATION

ヤギ

ナガホリ

OSAKA KOHKI

KOBAYASHI METALS

NARASAKI SANGYO

EDIUNET Related Ranking

EDIUNET

EDIUNET Credit Rating

EDIUNET Industry Avg

EDIUNET Prefectures

Yuho! Industry

EDIUNET Rating News

Prev « 2024-04 » Next

Mon	Tue	Wed	Thu	Fri	Sat	Sun
1 -	2 -	3 -	4 -	5 -	6 -	7 -
8 -	9 -	10 -	11 -	12 -	13 -	14 -
15 -	16 -	17 -	18 -	19 -	20 -	21 -
22 -	23 -	24 -	25 -	26 -	27 -	28 -
29 -	30 -

[Update list]

10/30 Real Estate (DAIBIRU:BBB→A e..

 RSS

 Company RSS

 Daily RSS

Sponsored Link

Recently Download Chart

NIPPON COKE & ENGINEERING

日本セラミック

日本セラミック

日本セラミック

日本セラミック

Credit Rating Analysis: YAMASHITA MEDICAL INSTRUMENTS (Annual )

The details of credit rating (bankruptcy risk) can be checked. A credit rating in nine stages (AAA-C).

【Analysis Menu】 Outline Statement Rating Indicator Download

Sponsored Link

Credit Rating (Bankruptcy Risk): YAMASHITA MEDICAL INSTRUMENTS (Annual ) Consolidated | Non-Consolidated

Date	Credit Rating	Comment	Sales	Current Profit	Net Income
2013-05-31	BBB	Credit is enough, but be decreased potential by biz environs.	¥ 47 B 6.34%	¥ 653 M 24.38%	¥ 402 M 99.00%

Financial Timeline

Date	2012-11-30  (Second quarter )	2013-02-28  (Third quarter )	2013-05-31  (Annual )	2013-08-31  (First quarter )
Credit Rating	CCC	BB	BBB	BB
Total Assets	¥ 15 B	¥ 15 B	¥ 17 B	¥ 15 B
Net Assets	¥ 5 B	¥ 5 B	¥ 5 B	¥ 5 B

Financial Statement Risk Analysis: YAMASHITA MEDICAL INSTRUMENTS (Annual ) (Consolidated )

Special note

Net sales has increased 5 consecutive terms. The performance is good.

[Date: 2013-05-31]  Danger : Warning : Caution : Good

Financing Good (*Operating Cash Flow is plus )
Investment Cash Flow (¥ -609 M) & Financial Cash Flow (¥ -61 M) is a minus, Operating Cash Flow (¥ 176 M) is a plus,

Dividend
Under the situation of Net Income (¥ 402 M) & Operating Cash Flow (¥ 176 M) , Dividend (¥ -61 M) is paid.

Financing Risk (*Operating Cash Flow is decrease )
Sales (¥ 47 B) is first term (¥ 44 B) more, however Operating Cash Flow (¥ 176 M) is first term (¥ 1 B) less , there is a possibility that the financing has deteriorated very much.

[Date: 2012-05-31]  Danger : Warning : Caution : Good

Financing Good (*Operating Cash Flow is plus )
Investment Cash Flow (¥ -33 M) & Financial Cash Flow (¥ -25 M) is a minus, Operating Cash Flow (¥ 1 B) is a plus,

Dividend
Under the situation of Net Income (¥ 202 M) & Operating Cash Flow (¥ 1 B) , Dividend (¥ -25 M) is paid.

[Date: 2011-05-31]  Danger : Warning : Caution : Good

Management Risk (*Net Income & Operating Cash Flow is minus or 0 )
Net Income(¥ -236 M) & Operating Cash Flow (¥ -1 B) is minus or 0, so , there is a possibility that the management situation is very severe.

Management Risk (*Net Income is decrease )
Net Income (¥ -236 M) is first term Net Income (¥ 186 M) less , there is a possibility that the management situation has stagnated and deteriorated

Management Risk (*Net Profit Margin is decrease )
Net Profit Margin (-0.59％) is first term Net Profit Margin (0.47％) less , there is a possibility that the profitability has deteriorated.

Dividend Risk
Under the situation of Net Income (¥ -236 M) & Operating Cash Flow (¥ -1 B), Dividend (¥ -76 M) is paid.

Financing Risk (*Operating Cash Flow is decrease )
Sales (¥ 40 B) is first term (¥ 39 B) more, however Operating Cash Flow (¥ -1 B) is first term (¥ 1 B) less , there is a possibility that the financing has deteriorated very much.

Non-performing asset Risk
Net Income (¥ -236 M) Operating Cash Flow (¥ -1 B) is a minus, Other Current Assets (¥ 10 B) - more than 50% of Total Assets (¥ 15 B) is occupied , there is a possibility of holding the non-performing asset.

Non-performing asset Risk (*Accounts Receivable and Inventory, etc. confirmed content)
Other Current Assets first term ratio (¥ 1 B) is Sales first term ratio (¥ 693 M) more , there is a possibility that the non-performing asset was increased.

Overinvestment Risk (*Intangible Assets confirmed content)
Operating Cash Flow (¥ -1 B) and Investment Cash Flow (¥ -111 M) is minus, so , there is a possibility of the overinvestment.

[Date: 2010-05-31]  Danger : Warning : Caution : Good

Financing Good (*Operating Cash Flow is plus )
Investment Cash Flow (¥ -150 M) & Financial Cash Flow (¥ -76 M) is a minus, Operating Cash Flow (¥ 1 B) is a plus,

Dividend
Under the situation of Net Income (¥ 186 M) & Operating Cash Flow (¥ 1 B) , Dividend (¥ -76 M) is paid.

[Date: 2009-05-31]  Danger : Warning : Caution : Good

Financing Good (*Operating Cash Flow is plus )
Investment Cash Flow (¥ -1 B) & Financial Cash Flow (¥ -77 M) is a minus, Operating Cash Flow (¥ 32 M) is a plus,

Dividend
Under the situation of Net Income (¥ 139 M) & Operating Cash Flow (¥ 32 M) , Dividend (¥ -76 M) is paid.

Credit Rating (Bankruptcy Risk): YAMASHITA MEDICAL INSTRUMENTS (Annual ) Consolidated | Non-Consolidated

Date	Credit Rating	Comment	Sales	Current Profit	Net Income
2013-05-31	BBB	Credit is enough, but be decreased potential by biz environs.	¥ 46 B 6.41%	¥ 641 M 21.40%	¥ 397 M 94.60%

Financial Timeline

Date	-  (First quarter )	-  (Second quarter )	-  (Third quarter )	2013-05-31  (Annual )
Credit Rating	-	-	-	BBB
Total Assets	-	-	-	¥ 17 B
Net Assets	-	-	-	¥ 5 B

Financial Statement Risk Analysis: YAMASHITA MEDICAL INSTRUMENTS (Annual ) (Non-Consolidated )

Special note

Net sales has increased 5 consecutive terms. The performance is good.

[Date: 2013-05-31]  Danger : Warning : Caution : Good

Dividend
Under the situation of Net Income (¥ 397 M) & Operating Cash Flow (-) , Dividend (¥ -61 M) is paid.

[Date: 2012-05-31]  Danger : Warning : Caution : Good

Dividend
Under the situation of Net Income (¥ 204 M) & Operating Cash Flow (-) , Dividend (¥ -25 M) is paid.

[Date: 2011-05-31]  Danger : Warning : Caution : Good

Management Risk (*Net Income is minus or 0 )
Net Income (¥ -277 M) is minus or 0, so , there is a possibility that the management situation is severe.

Management Risk (*Net Income is decrease )
Net Income (¥ -277 M) is first term Net Income (¥ 170 M) less , there is a possibility that the management situation has stagnated and deteriorated

Management Risk (*Net Profit Margin is decrease )
Net Profit Margin (-0.69％) is first term Net Profit Margin (0.43％) less , there is a possibility that the profitability has deteriorated.

Dividend
Under the situation of Net Income (¥ -277 M) & Operating Cash Flow (-) , Dividend (¥ -76 M) is paid.

Non-performing asset Risk
Net Income (¥ -277 M) is a minus, Other Current Assets (¥ 10 B) - more than 50% of Total Assets (¥ 15 B) is occupied , there is a possibility of holding the non-performing asset.

Non-performing asset Risk (*Accounts Receivable and Inventory, etc. confirmed content)
Other Current Assets first term ratio (¥ 1 B) is Sales first term ratio (¥ 717 M) more , there is a possibility that the non-performing asset was increased.

[Date: 2010-05-31]  Danger : Warning : Caution : Good

Dividend
Under the situation of Net Income (¥ 170 M) & Operating Cash Flow (-) , Dividend (¥ -76 M) is paid.

[Date: 2009-05-31]  Danger : Warning : Caution : Good

Dividend
Under the situation of Net Income (¥ 148 M) & Operating Cash Flow (-) , Dividend (¥ -76 M) is paid.

Related Information: YAMASHITA MEDICAL INSTRUMENTS (Annual )

Statement Type

Annual : YAMASHITA MEDICAL INSTRUMENTS

First quarter : YAMASHITA MEDICAL INSTRUMENTS

Second quarter : YAMASHITA MEDICAL INSTRUMENTS

Third quarter : YAMASHITA MEDICAL INSTRUMENTS

Analysis Menu

Outline : YAMASHITA MEDICAL INSTRUMENTS

Statement : YAMASHITA MEDICAL INSTRUMENTS

Rating : YAMASHITA MEDICAL INSTRUMENTS

Indicator : YAMASHITA MEDICAL INSTRUMENTS

Download : YAMASHITA MEDICAL INSTRUMENTS

Industry Comparison Ranking

Wholesale Trade - EDIUNET Industry Rankings

Wholesale Trade - EDIUNET Credit Rating

Wholesale Trade - EDIUNET Industry Avg

Comparison with a neighboring company

Nagasaki - EDIUNET Prefectures

Nagasaki佐世保市 - EDIUNET Prefectures

Related company's newest statement

Date	Company	Credit Rating	Date
1/20	リーバイ・ストラウス　..	C	2013-11-30
1/20	TIEMCO	BB	2013-11-30
1/15	イワキ	BBB	2013-11-30
1/15	マルカキカイ	BBB	2013-11-30
1/15	ALTECH	BB	2013-11-30
1/15	Shinwa	BBB	2013-11-30 (Q1)
1/15	ONWARD HOLDINGS	A	2013-11-30 (Q3)
1/15	ガリバーインターナショ..	BBB	2013-11-30 (Q3)
1/15	Morito	A	2013-11-30
1/15	BIKE O	BB→BBB	2013-11-30

EDIUNET Investment News (Wholesale Trade)

1/20 Wholesale Trade (リーバイ・..

1/15 Wholesale Trade (イワキ:BBB ..

1/10 Wholesale Trade (エコーＴＤ:..

1/9 Wholesale Trade (KITAKEI:BBB)

1/8 Wholesale Trade (F&A AQUA HO..

1/7 Wholesale Trade (Wakita:A)

1/6 Wholesale Trade (ADVAN:AA)

12/27 Wholesale Trade (ADVANCE:CC ..

12/26 Wholesale Trade (NAGAILEBEN:..

. Wholesale Trade (OOMITSU CO...

Company Information

Ticker	Market	Industry	Month	report	Rating
YAMASHITA MEDICAL INSTRUMENTS	3022	TSE 1st	Wholesale Trade	5	Annual	BBB

Related Company

COSMO BIO COMPANY,LIMITED (Sales ¥ 7 B)

Japan Lifeline (Sales ¥ 21 B)

DAIKO DENSHI TSUSHIN (Sales ¥ 33 B)

TOKYO BOEKI (Sales ¥ 46 B)

TOKYO ELECTRON DEVICE (Sales ¥ 85 B)

マルイチ産商 (Sales ¥ 159 B)

SANKYO KASEI (Sales ¥ 19 B)

TSUKAMOTO CORPORATION (Sales ¥ 33 B)

Chiyoda Kohan (Sales ¥ 38 B)

CHUO BUSSAN (Sales ¥ 132 B)

SATORI ELECTRIC (Sales ¥ 129 B)

KOBAYASHI METALS (Sales ¥ 19 B)

エコーＴＤ (Sales ¥ 75 B)

関連する株式投資情報

EDIUNET Caution

*Financial data might be different from the actual one. Please confirm the original, and read Caution.

*This site has obtained the information from the FSA's EDINET, Tokyo Stock Exchange's TDnet and Pay statistical data services, Fukuoka stock Exchange's Stock market capitalization, Center for Spatial Information Science's CSV Geocoding Service. The copyright of the information belongs to each corporation etc. .